Live Breaking News & Updates on Accelerated Access Collaborative

Stay updated with breaking news from Accelerated access collaborative. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods

TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
bmj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bmj.com Daily Mail and Mail on Sunday newspapers.

Northern Cape , South Africa , United States , United Kingdom , University College , New South Wales , Dan Adler , Richiardi Jonas , Victor Castro , Stacey Fisher , Boris Janssen , Laure Wynants , Vinyas Harish , Daniel Stahl , Viknesh Sounderajah , Evangelos Kanoulas , Conrad Harrison , Alex Garaiman , Junfeng Wang , Brooke Levis , Frank Rademakers , Adrian Barnett , Van Leeuwen , Jie Ma , Zane Perkins , Rachel Kuo ,

The changing diagnostic testing paradigm

Despite laboratories’ longstanding reliance upon microbial culture for infectious disease identification, the pressures of the pandemic have incre. ....

United Kingdom , Dai Health , Accelerated Access Collaborative , Care Award ,

Inclisiran: Government's strategy to promote cholesterol lowering drug after Brexit was "spectacular failure," says insider

The government’s policy to fast track “innovative” drugs into the NHS to showcase the UK as a great place for industry has been described as “a pretty spectacular failure,” because of the way a test case using the cholesterol lowering drug inclisiran was received.

The rapid introduction of inclisiran into the UK was part of the government’s drive to help the country regain its “status as a science superpower” after Brexit,1 which would bypass some of the usual routes to getting a drug into clinical practice.

The policy was widely supported across government, including by the Department of Health and Social Care, the Department for International Trade, NHS England, the Department of Business, Energy and Industrial Strategy, the Department of Science, Innovation and Technology, and the Office for Life Sciences.

Emails from 2021 obtained through freedom of information requests show that the health minister James Bethell had a meeting with Novartis wher ....

United Kingdom , Stephen Powis , Margaret Mccartney , James Bethell , Matt Whitty , Deborah Cohen , Tim Ferris , Department Of Health , Department Of Business , Department Of Science , Office Of Life Sciences , Department For International , Office For Life Sciences , Social Care , International Trade , Industrial Strategy , Life Sciences , Accelerated Access Collaborative , Vas Narasimhan ,

Inclisiran: the 'extremely unusual' political influence behind the novel drug's approval

The Pharmaceutical Journal from the Royal Pharmaceutical Society ....

United States , San Francisco , United Kingdom , Paula Byrne , Oxford Novartis , Chris Mccabe , Matt Hancock , University Of Galway , Medicines Company , Life Sciences , Jp Morgan , National Institute For Health , Department For International , Business Services Authority , Queen University Belfast , Office For Life Sciences , British Medical Association , University Of Oxford See Box , Department Of Health , Royal College , University Of Oxford , National Institute For Health Research , David Prior , National Institute , Care Excellence , Social Care ,

PJ view: Transparency in the science behind government policy is vital

The Pharmaceutical Journal from the Royal Pharmaceutical Society ....

United Kingdom , Robert Michell , Riyaz Patel , National Institute For Health , Health Systems , University Of Birmingham , Journal Of Pharmaceutical Health Services Researchinvites , British Heart Foundation , Barts Health , Department Of Health , University Of Oxford , Pharmaceutical Journal , Social Care , National Institute , Care Excellence , Term Plan , British Medical Journal , Information Act , Accelerated Access Collaborative , Pharmaceutical Health Services Researchinvites ,